Skip to main content
Log in

Torasemide in comparison with thiazides in the treatment of hypertension

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

There are a number of clinically relevant differences between torasemide and the thiazide diuretics in the treatment of hypertension. Only 2.5–5 mg torasemide once daily is sufficient for antihypertensive treatment; these low doses of torasemide exert comparable antihypertensive effects to those of the overtly natriuretic doses of thiazides (e.g., hydrochlorothiazide 25 mg) that are currently used once daily for the treatment of hypertension. Whereas natriuretic thiazide doses reduce blood pressure rapidly, the blood pressure-lowering effect of low-dose torasemide appears to occur more gradually during the first weeks of treatment. The diurnal blood pressure rhythm is not altered by either drug. In contrast to the thiazides, torasemide does not cause significant renal potassium loss in doses recommended to treat hypertension. Long-term antihypertensive treatment with torasemide has not resulted in undesired metabolic side effects, such as hypomagnesemia, alterations in glucose and lipid metabolism, or hyperuricemia. As compared with the thiazides, torasemide appears to be a safer and equally effective alternative for antihypertensive treatment when subdiuretic doses of this loop diuretic are used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Freis ED. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol level.Arch Intern Med 1988;149:2640–2648.

    Google Scholar 

  2. Reyes AJ, Leary WP, van der Byl K. Excretions of urinary fluid and solutes after single doses of furosemide and hydrochlorothiazide and of four different single doses of the diuretic torasemide in healthy subjects.Prog Pharmacol Clin Pharmacol 1990;8(1):47–71.

    Google Scholar 

  3. McMahon FG.Management of essential hypertension: The once-a-day era. 1990:297–378.

  4. Magee PFA, Freis ED. Is low-dose hydrochlorothiazide effective?Hypertension 1986;8:135–139.

    Google Scholar 

  5. Carlson JE, Kober L, Torp-Peterson C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect and adverse biochemical effects.Br Med J 1990;300:975–978.

    Google Scholar 

  6. Freis ED, Thomas JR, Fisher SG, et al. Effects of reduction in drugs or dosage after long-term control of systemic hypertension.Am J Cardiol 1989;63:702–708.

    PubMed  Google Scholar 

  7. Hollifield JW. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium and ventricular ectopy.Am J Med 1986;80(Suppl 4A):8–12.

    PubMed  Google Scholar 

  8. Khatri I, Materson BJ, Freis ED, et al. Blood pressure response to low and high-dose thiazide diuretic for the isolated systolic hypertension of the elderly (abstract).Hypertension 1987;10:370.

    Google Scholar 

  9. Kohvakka A, Salo H, Gordin A, et al. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.Acta Med Scand 1986;219:381–386.

    PubMed  Google Scholar 

  10. Kochar MS, Landry KM, Ristow SM. Effects of reduction in dose and discontinuation of hydrochlorothiazide in patients with controlled essential hypertension.Arch Intern Med 1990;150:1009–1011.

    PubMed  Google Scholar 

  11. Dupont AG, Schoors D, Six RO, et al. Antihypertensive efficacy of low dose torasemide in essential hypertension: A placebo-controlled study.J Human Hypertens 1988;2:265–268.

    Google Scholar 

  12. Achhammer I, Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide.Drugs 1991;41(Suppl 3):80–91.

    PubMed  Google Scholar 

  13. Porcellati C, Verdecchia P, Schillaci G et al. La torasemide, nuovo diuretico del'ansa, nel tratamento dell'ipertensione arteriosa. Studio controllato in doppia cecità.Basi Razion Ter 1990;20:407–410.

    Google Scholar 

  14. Baumgart P, Walger P, v. Eiff M, et al. Long-term efficacy and tolerance of torasemide in hypertension.Prog Pharmacol Clin Pharmacol 1990;8(1):169–181.

    Google Scholar 

  15. Reyes AJ, Chiesa PD, Santucci MR, et al. Hydrochlorothiazide versus a non-diuretic dose of torasemide as once-daily antihypertensive monopharmacotherapy in elderly patients. A randomized and double-blind study.Prog Pharmacol Clin Pharmacol 1990;8(1):183–209.

    Google Scholar 

  16. Spannbrucker N, Achhammer I, Metz P, et al. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.Arzneim Forsch/Drug Res 1988;38(I):190–193.

    Google Scholar 

  17. Achhammer I, Eberhard R. Comparison of serum potassium levels during long-term treatment of hypertensive patients with 2.5 mg torasemide/day or 50 mg triameterene/25 mg hydrochlorothiazide/day.Prog Pharmacol Clin Pharmacol 1990;8(1):211–220.

    Google Scholar 

  18. Boelke T, Achhammer I, Meyer-Sabellek WA, et al. Tages-und Nachrthythmik ambulanter 24-h Blutdruckwerte von älteren essentiellen Hypertonikern bei Therapie mit verschiedenen Antihypertonika.Hochdruck 1990;10:40.

    Google Scholar 

  19. Boelke T, Achhammer I, Meyer-Sabellek WA. Blutdrucksenkung und metabolische Veränderungen bei essentiellen Hypertonikern nach Langzeitgabe unterschiedlicher Diuretika.Hochdruck 1990;9:40–41.

    Google Scholar 

  20. Lacourcière Y, Provencher P. Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild-to-moderate essential hypertension.Br J Clin Pharmacol 1989;27:371–376.

    PubMed  Google Scholar 

  21. Carrageta O, Soares R, Martins A. The 24-hour ambulatory profile of blood pressure reduction with muzolimine.Clin Nephrol 1983;29(Suppl 1):114–115.

    Google Scholar 

  22. Reyes AJ, Leary WP, Alcocer L. The antihypertensive effect of diuretics: Overview and formal evaluation by the Montevideo Mathematical Model.Prog Pharmacol 1988;6(3):193–243.

    Google Scholar 

  23. Messerli FH. Antihypertensive therapy—is it different in the elderly?Drugs 1990;39(Suppl 2):49–54.

    Google Scholar 

  24. Peters RW, Hamilton J, Hamilton BP. Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension.South Med J 1989;82:966–969.

    PubMed  Google Scholar 

  25. Waite WW, Wade WE, Cobb HH. Effect of diuretic regimens on serum potassium.Can J Hosp Pharm 1988;41:243–247.

    Google Scholar 

  26. Morgan DB, Davidson C. Hypokalemia and diuretics. An analysis of publications.Br Med J 1980;905–908.

  27. Ames RP. The influence of non-beta-blocking drugs on the lipid profile: Are diuretics outclassed as initial therapy for hypertension?Am Heart J 1987;114:998–1006.

    PubMed  Google Scholar 

  28. Morgan TO. Metabolic effects of various antihypertensive agents.J Cardiovasc Pharmacol 1990;15(Suppl 5):39–45.

    Google Scholar 

  29. Goldman AI, Steele BW, Schnaper HW, et al. Serum lipoprotein levels during chlorthalidone therapy.JAMA 1980;224:1691–1695.

    Google Scholar 

  30. Lardinois CIK, Neumann SHL. The effects of antihypertensive agents on serum lipids and lipoproteins.Arch Intern Med 1988;148:1280–1288.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baumgart, P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drug Ther 7 (Suppl 1), 63–68 (1993). https://doi.org/10.1007/BF00877959

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877959

Key Words

Navigation